By Samanth Subramanian, Quartz
The US’ vast shortage in infant formula has one immediate cause: the suspension of operations in an Abbott Laboratories plant in Michigan earlier this year, after samples of a lethal bacteria were found in it. But beyond that lies a bigger structural problem plaguing the American economy: a tendency for many sectors to be controlled by a few companies, or even just one.
The baby food sector, for instance, is an oligopoly, in which two companies—Abbott and the Reckitt-owned Mead Johnson—dominate three-quarters of the market by sales. Further, the federal Women, Infants and Children (WIC) program, which offers supplemental nutrition for low-income families, buys and distributes nearly half of all baby formula in the US. The WIC program contracts with a specific company in each state, setting up a de facto monopoly situation. Abbott is the WIC’s contracted supplier in 34 states.
Featured News
Japanese Regulator Approves Korean Air’s Merger with Asiana Airlines
Jan 31, 2024 by
CPI
Netgear Files Antitrust Lawsuit Against Huawei Alleging Patent Misuse
Jan 31, 2024 by
CPI
Tennessee and Virginia Attorneys General Challenge NCAA’s NIL Rules in Federal Lawsuit
Jan 31, 2024 by
CPI
Argentina Appoints New Head Of Competition Commission
Jan 31, 2024 by
CPI
UK Antitrust Regulator Launches Probe into Supermarkets’ Loyalty Pricing
Jan 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI